Literature DB >> 26669347

Comment on: Traumatic central serous chorioretinopathy.

Manisha Agarwal1, Shalini Singh, Rahul Mayor, Ramesh Venkatesh.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26669347      PMCID: PMC4730708          DOI: 10.4103/0301-4738.171978

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
Dear Sir, We read with great interest the article titled “Traumatic central serous chorioretinopathy” by Steeples et al.[1] It is an interesting case of central serous chorioretinopathy developing after blunt trauma in a young 44-year-old Polynesian male patient. However, we would like to highlight the fact that this patient already had a preexisting history of central serous chorioretinopathy in the other eye probably secondary to his type A personality, which is said to be a predisposing factor for developing central serous chorioretinopathy secondary to increased endogenous corticosteroid levels.[2] In the case reported, the patient was already predisposed to developing central serous chorioretinopathy and the blunt trauma sustained by him could possibly have caused an increased stress level, and thereby leading to enhanced endogenous corticosteroid level and precipitating central serous chorioretinopathy, which possibly is unrelated to blunt trauma directly as the cause of the serous retinal detachment.

Financial support and sponsorship

Nil.

Conflicts of Interest

There are no conflicts of interest.
  2 in total

Review 1.  Review and update of central serous chorioretinopathy.

Authors:  Alexander Ross; Adam H Ross; Quresh Mohamed
Journal:  Curr Opin Ophthalmol       Date:  2011-05       Impact factor: 3.761

2.  Traumatic central serous chorioretinopathy.

Authors:  Laura Steeples; Vinod Sharma; Karl Mercieca
Journal:  Indian J Ophthalmol       Date:  2015-06       Impact factor: 1.848

  2 in total
  1 in total

1.  Authors' reply.

Authors:  Laura Steeples; Vinod Sharma; Karl Mercieca
Journal:  Indian J Ophthalmol       Date:  2015-11       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.